Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ATXI Avenue Therapeutics Inc

4,80

0,04 (0,84%)

Zuletzt aktualisiert: 15:35:04

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Avenue Therapeutics (NASDAQ:ATXI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Avenue Therapeutics Charts.

Avenue Therapeutics (NASDAQ:ATXI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Avenue Therapeutics Charts.

News Avenue Therapeutics Inc

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Montag 29 April 2024 (3 Tage vor) • GlobeNewswire Inc.

Avenue Therapeutics Announces Reverse Stock Split
Mittwoch 24 April 2024 (1 Woche vor) • GlobeNewswire Inc.

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Montag 18 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Freitag 15 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form PRE 14C - Other preliminary information statements
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
Donnerstag 22 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Freitag 2 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements
Montag 29 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 24 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Avenue Therapeutics Inc News-Artikel

Deutsche Lufthansa

Gold vs US Dollar

Euro vs US Dollar

Energy Select Sector SPDR

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen